REBA GIVENS: Open Payments
NPI 1275706129 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$474 in 5 payments from 5 companies in 2025. Trend: 2023 $360 · 2024 $780 · 2025 $474
Food & beverage: $474
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 1 | $117 |
| Gilead Sciences, Inc. | 1 | $107 |
| Phathom Pharmaceuticals, Inc. | 1 | $96 |
| AstraZeneca Pharmaceuticals LP | 1 | $88 |
| Novo Nordisk Inc | 1 | $66 |
Products named: MOUNJARO, Epclusa, VOQUEZNA, BREZTRI, Ozempic.
Industry payments across TX — which companies pay providers there.
